Back to Search
Start Over
Are there monogenic hereditary forms of bladder cancer or only genetic susceptibilities?
- Source :
- Pharmacogenomics. 22:619-628
- Publication Year :
- 2021
- Publisher :
- Future Medicine Ltd, 2021.
-
Abstract
- Bladder cancer (BC) is the most common cancer involving the urinary system and the ninth most common cancer worldwide. Tobacco smoking is the most important environmental risk factor of BC. Several single nucleotide polymorphisms have been validated by genome-wide association studies as genetic risk factors for BC. However, the identification of DNA mismatch-repair genes, including MSH2 in Lynch syndrome and MUTYH in MUTYH-associated polyposis, raises the possibility of monogenic hereditary forms of BC. Moreover, other genetic mutations may play a key role in familial and hereditary transmissions of BC. Therefore, the aim of this review is to focus on the major hereditary syndromes involved in the development of BC and to report BC genetic susceptibilities established with genome-wide significance level.
- Subjects :
- 0301 basic medicine
DNA Repair
Single-nucleotide polymorphism
030105 genetics & heredity
Biology
DNA Mismatch Repair
03 medical and health sciences
0302 clinical medicine
MUTYH
Genetics
medicine
Humans
Genetic Predisposition to Disease
Gene
Genetic association
Pharmacology
Bladder cancer
Cancer
medicine.disease
Lynch syndrome
Urinary Bladder Neoplasms
MSH2
Case-Control Studies
030220 oncology & carcinogenesis
Molecular Medicine
Genome-Wide Association Study
Subjects
Details
- ISSN :
- 17448042 and 14622416
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Pharmacogenomics
- Accession number :
- edsair.doi.dedup.....11af3dc3e522048a9bd14aea651a73b1
- Full Text :
- https://doi.org/10.2217/pgs-2020-0165